abstract |
The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating prostate cancer. SWI/SNF-related matrix-associated actin-dependent regulator of chromatin (SMARC) markers are provided, wherein changes in the levels of expression of one or more of the SMARC markers is correlated with the presence of prostate cancer. |